{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:29:54Z","timestamp":1748971794503,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"a grant from the National Center for Child Health and Development","award":["28-5"],"award-info":[{"award-number":["28-5"]}]},{"name":"Research Foundation for Clinical Pharmacology","award":["Clinical Pharmacology"],"award-info":[{"award-number":["Clinical Pharmacology"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12185-019-02795-8","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:05:16Z","timestamp":1576829116000},"page":"463-466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"111","author":[{"given":"Shin-ichi","family":"Tsujimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Utano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Osumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Kiyotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimikazu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5145-1774","authenticated-orcid":false,"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"2795_CR1","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.bbmt.2015.08.011","volume":"21","author":"H Ishida","year":"2015","unstructured":"Ishida H, Kato M, Kudo K, Taga T, Tomizawa D, Miyamura T, et al. Comparison of outcomes for pediatric patients with acute myeloid leukemia in remission and undergoing allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens based on either intravenous busulfan or total body irradiation: a report from the japanese society for hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2015;21:2141\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2795_CR2","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/pbc.25602","volume":"62","author":"M Kato","year":"2015","unstructured":"Kato M, Ishida H, Koh K, Inagaki J, Kato K, Goto H, et al. Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan society for hematopoietic cell transplantation. Pediatr Blood Cancer. 2015;62:1844\u201350.","journal-title":"Pediatr Blood Cancer."},{"key":"2795_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ped.13457","volume":"60","author":"M Kato","year":"2018","unstructured":"Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int. 2018;60:4\u201312.","journal-title":"Pediatr Int"},{"key":"2795_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12185-019-02684-0","volume":"110","author":"T Takachi","year":"2019","unstructured":"Takachi T, Arakawa Y, Nakamura H, Watanabe T, Aoki Y, Ohshima J, et al. Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia. Int J Hematol. 2019;110:355\u201363.","journal-title":"Int J Hematol"},{"key":"2795_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/oxfordjournals.annonc.a058131","volume":"3","author":"G Meloni","year":"1992","unstructured":"Meloni G, Raucci U, Pinto RM, Spalice A, Vignetti M, Iannetti P. Pretransplant conditioning with busulfan and cyclophosphamide in acute leukemia patients: neurological and electroencephalographic prospective study. Annals Oncol. 1992;3:145\u20138.","journal-title":"Annals Oncol"},{"key":"2795_CR6","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1592\/phco.28.12.1502","volume":"28","author":"AL Eberly","year":"2008","unstructured":"Eberly AL, Anderson GD, Bubalo JS, McCune JS. Optimal prevention of seizures induced by high-dose busulfan. Pharmacotherapy. 2008;28:1502\u201310.","journal-title":"Pharmacotherapy"},{"key":"2795_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12185-015-1756-6","volume":"101","author":"M Sato","year":"2015","unstructured":"Sato M, Kako S, Matsumoto K, Oshima K, Akahoshi Y, Nakano H, et al. Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation. Int J Hematol. 2015;101:497\u2013504.","journal-title":"Int J Hematol"},{"key":"2795_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11096-013-9768-x","volume":"35","author":"MS Diaz-Carrasco","year":"2013","unstructured":"Diaz-Carrasco MS, Olmos R, Blanquer M, Velasco J, Sanchez-Salinas A, Moraleda JM. Clonazepam for seizure prophylaxis in adult patients treated with high dose busulfan. Int J Clin Pharm. 2013;35:339\u201343.","journal-title":"Int J Clin Pharm"},{"key":"2795_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00686213","volume":"33","author":"M Hassan","year":"1993","unstructured":"Hassan M, Oberg G, Bjorkholm M, Wallin I, Lindgren M. Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. Cancer Chemother Pharmacol. 1993;33:181\u20136.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2795_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3109\/08880018.2010.496895","volume":"27","author":"AA Hamidieh","year":"2010","unstructured":"Hamidieh AA, Hamedani R, Hadjibabaie M, Amini M, Sadrai S, Ghavamzadeh A. Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study. Pediatr Hematol Oncol. 2010;27:529\u201333.","journal-title":"Pediatr Hematol Oncol"},{"key":"2795_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/pbc.24126","volume":"59","author":"S Soni","year":"2012","unstructured":"Soni S, Skeens M, Termuhlen AM, Bajwa RP, Gross TG, Pai V. Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2012;59:762\u20134.","journal-title":"Pediatr Blood Cancer"},{"key":"2795_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00280-018-3659-8","volume":"82","author":"K Akiyama","year":"2018","unstructured":"Akiyama K, Kume T, Fukaya M, Shiki I, Enami T, Tatara R, et al. Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients. Cancer Chemother Pharmacol. 2018;82:717\u201321.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2795_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2795_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB, et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol. 1989;25:55\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2795_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.braindev.2016.09.008","volume":"39","author":"K Muramatsu","year":"2017","unstructured":"Muramatsu K, Sawaura N, Ogata T, et al. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy. Brain Dev. 2017;39:231\u20135.","journal-title":"Brain Dev"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02795-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02795-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02795-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T00:54:40Z","timestamp":1608339280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02795-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02795-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no support from any organization for the submitted work (apart from that mentioned in the Acknowledgement section above), no financial relationships with any organizations that might have an interest in the submitted work in the previous 3\u00a0years and no other relationships or activities that could appear to have influenced the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}